Oruka Therapeutics, Inc. Share Price & Technical Analysis
ORKA · $60.61 (+3.27%)
Healthcare / Biotechnology
$60.61
+3.27%
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-1…
Price chart
Seasonality
May has 4 positive and 1 negative years (last 5 years shown)
-12% return in May, 5% avg return in past 3 year May month.
88% return in 2026, 24% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 13% | 0% | 49% | 37% | -12% | – | – | – | – | – | – | – | 88% |
| 25 | -32% | -27% | 1% | 2% | 2% | 2% | 21% | 10% | 30% | 48% | 7% | 3% | 66% |
| 24 | -6% | 3% | 6% | 96% | 6% | -4% | -22% | -19% | -4% | 13% | -23% | -13% | 32% |
| 23 | -8% | 0% | -9% | 1% | 8% | -3% | 2% | 0% | -2% | -11% | 2% | -6% | -27% |
| 22 | -13% | 7% | 15% | 33% | 0% | 5% | 0% | -3% | -12% | 4% | -5% | 16% | 48% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Uptrend · Neutral
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$3.79B
P/E ratio
—
52W high
$91.00
52W low
$10.64
Volume
11,01,798
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Oruka Therapeutics, Inc. share price today?
- Oruka Therapeutics, Inc. (ORKA) last traded around $60.61 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ORKA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ORKA. Download the app for real-time alerts.
- How can I analyze Oruka Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.